· Periodic Report
Q3 operating loss of KRW 0.3 billion on revenue of KRW 13.8 billion
Joa Pharm sold KRW 13.8 billion in Q3 but lost KRW 0.3 billion from its main business; sales fell 10.7% from a year earlier and 9.0% from the prior quarter.
034940 · KOSDAQ · Based on DART filings
1 total · 20 per page
· Periodic Report
Joa Pharm sold KRW 13.8 billion in Q3 but lost KRW 0.3 billion from its main business; sales fell 10.7% from a year earlier and 9.0% from the prior quarter.
Get app alerts for new disclosures from ChoA Pharmaceutical Co., LTD..